Cresset Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Sell |
25,000
-978
| -4% | -$1.4K | ﹤0.01% | 1611 |
|
|
2025
Q1 | $41.6K | Buy |
25,978
+978
| +4% | +$1.57K | ﹤0.01% | 1622 |
|
|
2024
Q4 | $90K | Hold |
25,000
| – | – | ﹤0.01% | 1600 |
|
|
2024
Q3 | $143K | Hold |
25,000
| – | – | ﹤0.01% | 1973 |
|
|
2024
Q2 | $116K | Buy |
+25,000
| New | +$116K | ﹤0.01% | 1899 |
|
|
2024
Q1 | – | Sell |
-25,000
| Closed | -$141K | – | 1886 |
|
|
2023
Q4 | $141K | Hold |
25,000
| – | – | ﹤0.01% | 1706 |
|
|
2023
Q3 | $46.5K | Buy |
25,000
+5,000
| +25% | +$9.3K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $55K | Buy |
20,000
+8,719
| +77% | +$24K | ﹤0.01% | 1707 |
|
|
2023
Q1 | $35.4K | Sell |
11,281
-34,600
| -75% | -$109K | ﹤0.01% | 796 |
|
|
2022
Q4 | $268K | Hold |
45,881
| – | – | ﹤0.01% | 563 |
|
|
2022
Q3 | $402K | Sell |
45,881
-5,536
| -11% | -$48.5K | 0.01% | 574 |
|
|
2022
Q2 | $387K | Buy |
51,417
+6,036
| +13% | +$45.4K | ﹤0.01% | 636 |
|
|
2022
Q1 | $1.1M | Buy |
45,381
+2,000
| +5% | +$48.5K | 0.01% | 383 |
|
|
2021
Q4 | $1.4M | Buy |
+43,381
| New | +$1.4M | 0.01% | 364 |
|